vorapaxar sulfate M-9 - Names and Identifiers
Name | vorapaxar sulfate M-9
|
Synonyms | vorapaxar sulfate M-9 ethyl((1R,3aR,6R,8aS,9S,9aS)-9-(diphenylcarbamoyl)-1-methyl-3-oxo-1,3,3a,5,6,7,8,8a,9,9a-decahydronaphtho[2,3-c]furan-6-yl)carbamate Carbamic acid, [(1R,3aR,6R,8aS,9S,9aS)-9-[(diphenylamino)carbonyl]-1,3,3a,5,6,7,8,8a,9,9a-decahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, ethyl este
|
CAS | 900161-11-7
|
vorapaxar sulfate M-9 - Physico-chemical Properties
vorapaxar sulfate M-9 - Upstream Downstream Industry
vorapaxar sulfate M-9 - Introduction
vorapaxar sulfate M-9(vorapaxar sulfate M-9) is a platelet protein receptor antagonist that acts by inhibiting the activation of the platelet protein PAR-1. It is a white crystalline solid with the chemical name (N-(4-((4-(4-(benzylsulfonyl)piperazin-1-ylmethyl)phenyl)amino)quinazolin-6-yl)methanesulfonamide).
The primary use of vorapaxar sulfate M-9 is to prevent thrombosis. It is used to reduce the risk of cardiovascular events, especially in patients at high risk of myocardial infarction or stroke. vorapaxar sulfate M-9 reduce thrombus formation by inhibiting platelet aggregation and gelation.
The preparation method of vorapaxar sulfate M-9 includes the reaction and purification and separation of synthetic raw materials. During the preparation process, pay attention to safe operation, avoid contact with skin and eyes, and prevent inhalation or swallowing.
Regarding safety information, vorapaxar sulfate M-9 may cause allergic reactions in certain populations. During use, you should pay close attention to any adverse reactions and seek medical attention when needed. In addition, patients who are at risk of bleeding or are on other anticoagulant therapy should avoid vorapaxar sulfate M-9.
This is a general introduction, please consult your doctor or pharmacist for more detailed information before specific application.
Last Update:2024-04-09 20:52:54